181 related articles for article (PubMed ID: 31251364)
21. Urinary creatinine excretion, measured glomerular filtration rate and CKD outcomes.
Tynkevich E; Flamant M; Haymann JP; Metzger M; Thervet E; Boffa JJ; Vrtovsnik F; Houillier P; Froissart M; Stengel B;
Nephrol Dial Transplant; 2015 Aug; 30(8):1386-94. PubMed ID: 25817225
[TBL] [Abstract][Full Text] [Related]
22. Obesity is not associated with progression to end stage renal disease in patients with biopsy-proven glomerular diseases.
Elyan BMP; Lees JS; Gillis KA; Mackinnon B; Fox JG; Geddes CC; McQuarrie EP
BMC Nephrol; 2019 Jul; 20(1):237. PubMed ID: 31266462
[TBL] [Abstract][Full Text] [Related]
23. Demographic and health-related predictors of proton pump inhibitor (PPI) use and association with chronic kidney disease (CKD) stage in NHANES population.
Devraj R; Deshpande M
Res Social Adm Pharm; 2020 Jun; 16(6):776-782. PubMed ID: 31445985
[TBL] [Abstract][Full Text] [Related]
24. Nonproteinuric Versus Proteinuric Phenotypes in Diabetic Kidney Disease: A Propensity Score-Matched Analysis of a Nationwide, Biopsy-Based Cohort Study.
Yamanouchi M; Furuichi K; Hoshino J; Toyama T; Hara A; Shimizu M; Kinowaki K; Fujii T; Ohashi K; Yuzawa Y; Kitamura H; Suzuki Y; Sato H; Uesugi N; Hisano S; Ueda Y; Nishi S; Yokoyama H; Nishino T; Samejima K; Kohagura K; Shibagaki Y; Mise K; Makino H; Matsuo S; Ubara Y; Wada T;
Diabetes Care; 2019 May; 42(5):891-902. PubMed ID: 30833372
[TBL] [Abstract][Full Text] [Related]
25. The association between proton pump inhibitor use and the risk of adverse kidney outcomes: a systematic review and meta-analysis.
Nochaiwong S; Ruengorn C; Awiphan R; Koyratkoson K; Chaisai C; Noppakun K; Chongruksut W; Thavorn K
Nephrol Dial Transplant; 2018 Feb; 33(2):331-342. PubMed ID: 28339835
[TBL] [Abstract][Full Text] [Related]
26. Risk Prediction for Early CKD in Type 2 Diabetes.
Dunkler D; Gao P; Lee SF; Heinze G; Clase CM; Tobe S; Teo KK; Gerstein H; Mann JF; Oberbauer R;
Clin J Am Soc Nephrol; 2015 Aug; 10(8):1371-9. PubMed ID: 26175542
[TBL] [Abstract][Full Text] [Related]
27. The association of proton pump inhibitors and chronic kidney disease: cause or confounding?
Li T; Xie Y; Al-Aly Z
Curr Opin Nephrol Hypertens; 2018 May; 27(3):182-187. PubMed ID: 29432214
[TBL] [Abstract][Full Text] [Related]
28. Using proton pump inhibitors correlates with an increased risk of chronic kidney disease: a nationwide database-derived case-controlled study.
Hung SC; Liao KF; Hung HC; Lin CL; Lai SW; Lee PC; Hung SR
Fam Pract; 2018 Mar; 35(2):166-171. PubMed ID: 29045621
[TBL] [Abstract][Full Text] [Related]
29. Contemporary rates and predictors of fast progression of chronic kidney disease in adults with and without diabetes mellitus.
Go AS; Yang J; Tan TC; Cabrera CS; Stefansson BV; Greasley PJ; Ordonez JD;
BMC Nephrol; 2018 Jun; 19(1):146. PubMed ID: 29929484
[TBL] [Abstract][Full Text] [Related]
30. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.
Perkins RM; Kirchner HL; Hartle JE; Bucaloiu ID
Clin Nephrol; 2013 Oct; 80(4):256-62. PubMed ID: 23993165
[TBL] [Abstract][Full Text] [Related]
31. Declining Estimated Glomerular Filtration Rate and Its Association with Mortality and Comorbidity Over 10 Years in Elderly Women.
Malmgren L; McGuigan FE; Berglundh S; Westman K; Christensson A; Åkesson K
Nephron; 2015; 130(4):245-55. PubMed ID: 26184510
[TBL] [Abstract][Full Text] [Related]
32. Mortality and Renal Replacement Therapy after Renal Artery Stent Placement for Atherosclerotic Renovascular Disease.
Misra S; Khosla A; Allred J; Harmsen WS; Textor SC; McKusick MA
J Vasc Interv Radiol; 2016 Aug; 27(8):1215-24. PubMed ID: 27296703
[TBL] [Abstract][Full Text] [Related]
33. Is there a relationship between hypomagnesemia and proton-pump inhibitors in patients on chronic hemodialysis?
Mikolasevic I; Milic S; Stimac D; Zaputovic L; Lukenda Zanko V; Gulin T; Jakopcic I; Klaric D; Gulin M; Orlic L
Eur J Intern Med; 2016 May; 30():99-103. PubMed ID: 26905320
[TBL] [Abstract][Full Text] [Related]
34. Circulating α-klotho levels in CKD and relationship to progression.
Kim HR; Nam BY; Kim DW; Kang MW; Han JH; Lee MJ; Shin DH; Doh FM; Koo HM; Ko KI; Kim CH; Oh HJ; Yoo TH; Kang SW; Han DS; Han SH
Am J Kidney Dis; 2013 Jun; 61(6):899-909. PubMed ID: 23540260
[TBL] [Abstract][Full Text] [Related]
35. Associations of Proton-Pump Inhibitors and H2 Receptor Antagonists with Chronic Kidney Disease: A Meta-Analysis.
Wijarnpreecha K; Thongprayoon C; Chesdachai S; Panjawatanana P; Ungprasert P; Cheungpasitporn W
Dig Dis Sci; 2017 Oct; 62(10):2821-2827. PubMed ID: 28836158
[TBL] [Abstract][Full Text] [Related]
36. Time-dependent risk factors associated with the decline of estimated GFR in CKD patients.
Chang WX; Arai S; Tamura Y; Kumagai T; Ota T; Shibata S; Fujigaki Y; Shen ZY; Uchida S
Clin Exp Nephrol; 2016 Feb; 20(1):58-70. PubMed ID: 26100399
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of chronic kidney diseases in patients with chronic obstructive pulmonary disease: assessment based on glomerular filtration rate estimated from creatinine and cystatin C levels.
Yoshizawa T; Okada K; Furuichi S; Ishiguro T; Yoshizawa A; Akahoshi T; Gon Y; Akashiba T; Hosokawa Y; Hashimoto S
Int J Chron Obstruct Pulmon Dis; 2015; 10():1283-9. PubMed ID: 26185434
[TBL] [Abstract][Full Text] [Related]
38. Kidney function decline associated with proton pump inhibitors: results from the ELSA-Brasil cohort.
Dos Santos AS; de Menezes ST; Silva IR; Oliveira WN; Pereira ML; Mill JG; Barreto SM; Figueiredo RC
BMC Nephrol; 2023 Sep; 24(1):285. PubMed ID: 37770872
[TBL] [Abstract][Full Text] [Related]
39. Proton pump inhibitor as an independent factor of progression of abdominal aortic calcification in patients on maintenance hemodialysis.
Okamoto T; Hatakeyama S; Hosogoe S; Tanaka Y; Imanishi K; Takashima T; Saitoh F; Suzuki T; Ohyama C
PLoS One; 2018; 13(7):e0199160. PubMed ID: 29969455
[TBL] [Abstract][Full Text] [Related]
40. Estimated Glomerular Filtration Rate Within the Normal or Mildly Impaired Range and Incident Cardiovascular Disease.
Eisen A; Hoshen M; Balicer RD; Reges O; Rabi Y; Leibowitz M; Iakobishvili Z; Hasdai D
Am J Med; 2015 Sep; 128(9):1015-22.e2. PubMed ID: 25863153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
